arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

PharmaCyte Biotech, Inc.

PMCB
$0.35
▲ +2.3% Today
as of Oct 22, 16:51 ET
Last 30 days -10.71% Sep 14 → Oct 22
$0.33 $0.37 $0.40 $0.43 $0.47 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$0.37
High
$0.37
Low
$0.34
Volume
$32,897
Avg Vol
$996,192
Mkt Cap
$5M
P/E (TTM)
—
Beta
—
52w High
$1.51
52w Low
$0.33
Div Yield
—
Shares Out
$11M

PMCB earnings at a glance

The options market is pricing a move of about ±1213.3% after the report, a range of roughly -$3.90 to $4.60 from today's $0.35. Implied volatility is currently 103%. The share price of $0.35 sits near its 52-week low.

All stocks · Earnings calendar

Overview

52-week range
$0.33
$1.51
1% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Latest IV / EM
10272%
EM ±1213.3% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.65$-0.01$0.62$1.26$1.90 Actual $-0.09Actual $-0.04Actual $-0.54Actual $-0.26Actual $-0.65Actual $1.90Actual $-0.39Actual $-0.44Actual $-0.25Actual $-0.09Actual $-0.17Actual $-0.54 OctJanJulOctJanJulOctJanApr/2025Jul/2025JanJul
Revenue vs Net Income Revenue Net income
$-8M$-121,966$8M$16M$25M Jul 24Oct 24Jan 25Jul 25Oct 25Jan 26Jul 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri Jul 31, 2026Jul 2026 $-0.54 — — — — financials
Sat Jan 31, 2026Jan 2026 $-0.17 — — — — financials
Mon Sep 15, 2025Jul/2025 $-0.09 — — — — earnings
Fri Aug 8, 2025Apr/2025 $-0.25 — — — — earnings
Fri Jan 31, 2025Jan 2025 $-0.44 — — — — financials
Thu Oct 31, 2024Oct 2024 $-0.39 — — — — financials
Wed Jul 31, 2024Jul 2024 $1.90 — — — — financials
Wed Jan 31, 2024Jan 2024 $-0.65 — — — — financials
Tue Oct 31, 2023Oct 2023 $-0.26 — — — — financials
Mon Jul 31, 2023Jul 2023 $-0.54 — — — — financials
Tue Jan 31, 2023Jan 2023 $-0.04 — — — — financials
Mon Oct 31, 2022Oct 2022 $-0.09 — — — — financials
Sun Jul 31, 2022Jul 2022 $-0.07 — — — — financials

Financials

Income statement (quarterly)

MetricJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Jan 2025Oct 2024Jul 2024
Revenue$0—$0$0$0$0$0$0
Cost of revenue————————
Gross profit————————
Operating income$-1M—$-2M$-1M$-848,305$-960,252$-1M$-1M
Net income$-5M—$746,860$-7M$-8M$-3M$-1M$23M
EPS (diluted)$-0.54—$-0.17$-1.24$-1.23$-0.44$-0.39$1.90

Balance sheet (quarterly)

MetricJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Jan 2025Oct 2024Jul 2024
Cash & equivalents$18M$19M$20M$15M$13M$16M$21M$33M
Inventory————————
Total current assets$31M$37M$21M$23M$19M$17M$21M$33M
Total assets$37M$47M$56M$56M$45M$44M$55M$70M
Long-term debt————————
Total liabilities$7M$12M$16M$19M$2M$4M$12M$17M
Total equity$28M$33M$38M$35M$44M$40M$43M$48M

Implied volatility — last 90 days

3654%12252%20849%29446%38043% Jul 22 — IV 3655% · EM ±836.1%Jul 23 — IV 3896% · EM ±876.3%Jul 24 — IV 3997% · EM ±883.2%Jul 27 — IV 4216% · EM ±880.3%Jul 28 — IV 4225% · EM ±864.4%Jul 29 — IV 4349% · EM ±871.0%Jul 30 — IV 4339% · EM ±850.0%Sep 04 — IV 8550% · EM ±1336.1%Sep 07 — IV 9646% · EM ±1336.1%Sep 09 — IV 10985% · EM ±1376.3%Sep 10 — IV 4416% · EM ±521.7%Sep 11 — IV 8950% · EM ±988.9%Sep 14 — IV 20055% · EM ±1675.1%Sep 15 — IV 23505% · EM ±1700.2%Sep 16 — IV 19100% · EM ±1128.1%Sep 17 — IV 38044% · EM ±1588.8%Sep 21 — IV 7011% · EM ±1464.1%Sep 24 — IV 6040% · EM ±1183.2%Oct 08 — IV 10272% · EM ±1213.3%

PMCB earnings FAQ

What is PMCB's expected move for earnings?

Options currently price a move of about ±1213.3%, or $4.25 per share either way from $0.35.

What is PMCB's implied volatility?

PMCB's at-the-money implied volatility is about 103% based on the latest options snapshot.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.